Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27758544 | 1.00 | REN (0.69) | RENCYP3A4 | |
| SCHEMBL5509846 | 0.91 | REN (0.69) | RENCYP3A4 | |
| SCHEMBL5603647 | 0.91 | REN (0.69) | RENCYP3A4 | |
| SCHEMBL968276 | 0.90 | REN (0.68) | RENCYP3A4 | |
| SCHEMBL968278 | 0.90 | REN (0.68) | RENCYP3A4 | |
| SCHEMBL27689729 | 0.89 | REN (0.70) | RENCYP3A4 | |
| SCHEMBL5504703 | 0.89 | REN (0.70) | RENCYP3A4 | |
| SCHEMBL27737830 | 0.89 | REN (0.57) | RENCYP3A4 | |
| SCHEMBL27737831 | 0.89 | REN (0.57) | RENCYP3A4 | |
| SCHEMBL4755229 | 0.88 | REN (0.65) | RENCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101356156-B | Aspartic protease inhibitors | VITAE PHARMACEUTICALS INC | 2012-12-05 | — | — | CN | disclosed |
| CN-101356156-A | Aspartic protease inhibitors | VITAE PHARMACEUTICALS INC (US) | 2009-01-28 | — | — | CN | disclosed |
| WO-2008156832-A2 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2008-12-24 | — | — | WO | disclosed |
| EP-1966139-A1 | ASPARTIC PROTEASE INHIBITORS | Vitae Pharmaceuticals, Inc. (US) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007070201-A1 | ASPARTIC PROTEASE INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-06-21 | — | — | WO | disclosed |